Hidden clues in ovarian tissue: a study hunts for early cancer signals in BRCA carriers
NCT ID NCT07736300
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study investigates whether women with BRCA gene mutations have distinct molecular patterns in their ovarian tissue that could signal the very earliest stages of ovarian cancer. Researchers will analyze gene activity and DNA methylation in tissue samples from 30 women, including BRCA carriers with and without precancerous lesions (STIC) and women without BRCA mutations. The goal is to uncover biomarkers that might one day lead to better risk assessment and earlier detection of ovarian cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify early molecular markers for ovarian cancer risk in BRCA carriers, potentially improving early detection and prevention strategies.
- What could go wrong
- This is a small, exploratory study with only 30 participants. The findings may not translate into clinical tools without much larger validation studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA MUTATIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.